Milica Pešić

University of Belgrade — RS

Medicine · Health Sciences

35h-index3.7kcitations226works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Transport and Resistance Mechanisms(30), Cancer therapeutics and mechanisms(20), Natural product bioactivities and synthesis(17), Growth Hormone and Insulin-like Growth Factors(12), Glioma Diagnosis and Treatment(11)

Publications225 total

Editorial: Combination therapies in cancer treatment: enhancing efficacy and reducing resistance
Frontiers in Pharmacology·2026Open Access
Integrative lipophilicity assessment and pharmacokinetic correlation of pyrimidine precursors and artesunate–pyrimidine hybrids: development of QSAR models for anticancer activity and interaction with <i>P</i> -glycoprotein
Future Medicinal Chemistry·2025Open Access
Novel Adamantane–Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells
Molecules·2025· 1 citedOpen Access
Novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivity
Bioorganic Chemistry·2025
Phytochemical analysis, biological activities and molecular docking studies of black and white goji fruits of Lycium ruthenicum Murray
Food Chemistry·2025
PARP inhibition increases sensitivity to cisplatin in non-small-cell lung carcinoma via the induction of TET-dependent hydroxymethylation
Frontiers in Cell and Developmental Biology·2025· 1 citedOpen Access
Sclareol-based natural nanoparticles with adamantane moieties exert anticancer effects against non-small cell lung carcinoma cells
Bioorganic Chemistry·2025· 1 cited
Impact of ex vivo cell culturing on ABC transporters’ expression and drug sensitivity in patient-derived non-small cell lung cancer models
SHILAP Revista de lepidopterología·2025Open Access
Editorial on Special Issue: “Novel Therapeutic Strategies for Glioblastoma”
Pharmaceutics·2025Open Access
Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell Cultures
Current Issues in Molecular Biology·2025Open Access
Exploring SAR insights into royleanones for P-gp modulation
Biomedicine & Pharmacotherapy·2025Open Access
LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models
Pharmaceutics·2025· 1 citedOpen Access
New Evidence Supporting Female Protective Effect in Patients with Congenital Anomalies and Neurodevelopmental Disorders
SSRN Electronic Journal·2025Open Access
The assessment of rosehip (Rosa Canina L.) pseudo-fruit antioxidant capacity: Electrochemical vs. spectrophotometric methods pre and post in vitro gastrointestinal digestion
Hrana i ishrana·2025Open Access
Investigating SAR Insights into Royleanones for P-gp Modulation
2024· 1 citedOpen Access
Plant-Based Products Originating from Serbia That Affect P-glycoprotein Activity
Molecules·2024Open Access
Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine
Life·2024· 2 citedOpen Access
Editorial: Natural products and nanoparticles in cancer treatment: is there a light at the end of the tunnel?
Frontiers in Pharmacology·2024· 1 citedOpen Access
Significance of Duodenal Prolactin Receptor Modulation by Calcium and Vitamin D in Sulpiride-Induced Hyperprolactinemia
Medicina·2024· 2 citedOpen Access
Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors
Cancers·2024· 5 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Ana Podolski-Renić(19), Jasna Banković(16), Nikola Tanić(13), Tijana Stanković(13), Jelena Dinić(12), Sabera Ruždijić(8), Ivana Aljančić(6), Milka Jadranin(6), Vlatka Vajs(6), Vele Tešević(6), Ivanka Marković(5), Nina Todorović(5), Zorica Milošević(5), Slobodan Antić(4), Sonja Stojković(4), Miodrag Dragoj(4), Mirna Jovanović(4), Slobodan M. Milosavljević(3), Sonja Stojković Burić(3), Mikhail Krasavin(3)